Withdrawal of marketing authorisations of veterinary medicines containing Zinc Oxide

Background

In June 2017, the European Commission (EC) adopted a Commission Implementing Decision to withdraw, by 26 June 2022, the marketing authorisations (MAs) of veterinary medicines containing Zinc Oxide for oral administration to food-producing animals.

This Commission Implementing Decision forms part of retained EU law and therefore part of UK law.

See Veterinary medicines containing Zinc Oxide: European referral outcome , and Veterinary medicines containing Zinc Oxide: European Commission decision

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.